• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子α(TGF-α)和表皮生长因子受体(EGF-R)在人肝癌细胞中的协同及单独表达支持了人肝癌自分泌、旁分泌和内分泌生长的假说。

Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma.

作者信息

Yamaguchi K, Carr B I, Nalesnik M A

机构信息

Department of Transplant Surgery, University of Pittsburgh School of Medicine, Pennsylvania, USA.

出版信息

J Surg Oncol. 1995 Apr;58(4):240-5. doi: 10.1002/jso.2930580409.

DOI:10.1002/jso.2930580409
PMID:7723367
Abstract

Single and double immunohistochemical staining for transforming growth factor (TGF)-alpha and epidermal growth factor-receptor (EGF-R) was done in order to identify the localization of TGF-alpha and EGF-R in human hepatocellular carcinoma (HCC). Single immunohistochemical staining for TGF-alpha showed immunoreactivity in the cytoplasm of hepatoma cells in 22 of 30 cases of HCC. The localization of TGF-alpha was heterogeneous from HCC cells to HCC cells. In the surrounding regenerative nodules, the hepatocytes were mildly to moderately positive for TGF-alpha. The proliferating bile ductules and peripheral nerves were also immunopositive for TGF-alpha. Single immunohistochemical staining for EGF-R demonstrated a linear localization of EGF-R along the cell membrane of the HCC cells in 21 of the 30 cases of HCC. In the regenerative nodules, the hepatocytes also showed linear staining along the cell membrane. Double staining for TGF-alpha and EGF-R in 12 cases of HCC showed a concurrent localization of TGF-alpha and EGF-R in some hepatoma cells and isolated localization of the two substances of other HCC cells. These combinations either abruptly moved around or intermingled with each other. These immunohistochemical results thus support the theory of an autocrine, paracrine, and endocrine mechanism of TGF-alpha and EGF-R on the proliferation of human hepatocellular carcinoma.

摘要

为了确定转化生长因子(TGF)-α和表皮生长因子受体(EGF-R)在人肝细胞癌(HCC)中的定位,进行了TGF-α和EGF-R的单重和双重免疫组织化学染色。TGF-α的单重免疫组织化学染色显示,在30例HCC中的22例中,肝癌细胞的细胞质中有免疫反应性。TGF-α在肝癌细胞之间的定位是异质性的。在周围的再生结节中,肝细胞对TGF-α呈轻度至中度阳性。增殖的胆小管和周围神经对TGF-α也呈免疫阳性。EGF-R的单重免疫组织化学染色显示,在30例HCC中的21例中,EGF-R沿肝癌细胞膜呈线性定位。在再生结节中,肝细胞也沿细胞膜呈线性染色。12例HCC中TGF-α和EGF-R的双重染色显示,在一些肝癌细胞中TGF-α和EGF-R同时定位,而在其他肝癌细胞中这两种物质单独定位。这些组合要么突然移动,要么相互交织。因此,这些免疫组织化学结果支持了TGF-α和EGF-R对人肝细胞癌增殖的自分泌、旁分泌和内分泌机制的理论。

相似文献

1
Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma.转化生长因子α(TGF-α)和表皮生长因子受体(EGF-R)在人肝癌细胞中的协同及单独表达支持了人肝癌自分泌、旁分泌和内分泌生长的假说。
J Surg Oncol. 1995 Apr;58(4):240-5. doi: 10.1002/jso.2930580409.
2
Immunohistochemical and ultrastructural localization of epidermal growth factor receptor in human liver and hepatocellular carcinoma tissues.
Acta Pathol Jpn. 1990 Jan;40(1):22-9. doi: 10.1111/j.1440-1827.1990.tb01525.x.
3
Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.慢性肝病和肝细胞癌中的转化生长因子-α与表皮生长因子受体
Liver. 1999 Aug;19(4):318-25. doi: 10.1111/j.1478-3231.1999.tb00056.x.
4
Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance.转化生长因子-α及乙型肝炎表面抗原在人肝细胞癌组织中的表达及其意义
World J Gastroenterol. 2004 Mar 15;10(6):830-3. doi: 10.3748/wjg.v10.i6.830.
5
Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma.
Liver. 1997 Aug;17(4):177-82. doi: 10.1111/j.1600-0676.1997.tb00803.x.
6
Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.大鼠肝脏中二乙基亚硝胺诱导肝癌发生过程中ErbB受体蛋白和转化生长因子-α的表达
Korean J Hepatol. 2007 Mar;13(1):70-80.
7
Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.表皮生长因子家族及其受体在肝癌细胞系中的表达:与细胞增殖的关系
Int J Oncol. 1999 Mar;14(3):453-60. doi: 10.3892/ijo.14.3.453.
8
Transforming growth factor-alpha, epidermal growth factor, and epidermal growth factor receptor in human testis obtained from biopsy and castration: immunohistochemical study.从活检和阉割获取的人类睾丸中的转化生长因子-α、表皮生长因子及表皮生长因子受体:免疫组织化学研究
Tohoku J Exp Med. 1996 Apr;178(4):381-8. doi: 10.1620/tjem.178.381.
9
The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.转化生长因子-α在肝硬化、发育异常结节及肝细胞癌中的表达:70例免疫组织化学研究
Am J Surg Pathol. 2007 May;31(5):681-9. doi: 10.1097/PAS.0b013e31802ff7aa.
10
Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis.β细胞素和表皮生长因子受体在肝细胞癌中的表达:对血管生成的影响
Hum Pathol. 2006 Oct;37(10):1324-32. doi: 10.1016/j.humpath.2006.04.022. Epub 2006 Jul 27.

引用本文的文献

1
Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab.肝癌细胞系对尼妥珠单抗疗效的生物信息学分析
Int J Gen Med. 2021 Jun 17;14:2611-2621. doi: 10.2147/IJGM.S312770. eCollection 2021.
2
An Epitope on EGFR Loading Catastrophic Internalization Serve as a Novel Oncotarget for Hepatocellular Carcinoma Therapy.表皮生长因子受体(EGFR)上的一个表位引发灾难性内化,可作为肝细胞癌治疗的新型癌靶标。
Cancers (Basel). 2020 Feb 16;12(2):456. doi: 10.3390/cancers12020456.
3
Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.
肝细胞癌:分子靶向治疗的过去与未来
Diseases. 2015 Dec 25;4(1):1. doi: 10.3390/diseases4010001.
4
Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.基于溶瘤病毒的肝细胞癌免疫疗法
Mediators Inflamm. 2017;2017:5198798. doi: 10.1155/2017/5198798. Epub 2017 Apr 20.
5
Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate.Smad2和Smad3调节生长板中软骨细胞的增殖和分化。
PLoS Genet. 2016 Oct 14;12(10):e1006352. doi: 10.1371/journal.pgen.1006352. eCollection 2016 Oct.
6
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.表皮生长因子受体(EGFR)抑制剂吉非替尼可降低但不能预防化学和激素诱导的大鼠肝癌发生模型中的肿瘤发生。
Int J Mol Sci. 2016 Sep 23;17(10):1618. doi: 10.3390/ijms17101618.
7
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.贝伐珠单抗联合厄洛替尼治疗晚期肝细胞癌的 II 期研究。
Cancer. 2012 May 1;118(9):2424-30. doi: 10.1002/cncr.26556. Epub 2011 Sep 27.
8
New pharmacological developments in the treatment of hepatocellular cancer.肝细胞癌治疗的新药理学进展。
Drugs. 2009;69(18):2533-40. doi: 10.2165/11530870-000000000-00000.
9
Experimental models of hepatocellular carcinoma.肝细胞癌的实验模型
J Hepatol. 2008 May;48(5):858-79. doi: 10.1016/j.jhep.2008.01.008. Epub 2008 Jan 30.
10
Roles of EGFR-Stat3 signal pathway in carcinogenesis of experimental hepatoma in rats.表皮生长因子受体-信号转导和转录激活因子3信号通路在大鼠实验性肝癌发生中的作用
J Cancer Res Clin Oncol. 2007 Mar;133(3):145-52. doi: 10.1007/s00432-006-0139-z. Epub 2006 Oct 10.